Loading…
Operates in Healthcare Services — In-patient & out-patient services. Per the activity note to the FY2023 annual report, the company operates hospital for war veterans. Founded 30 October 2007.
Subsidiary of Sakhelmtsipo (100.0%)
| Ratio | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Margins | ||||
| Gross Margin | 99.0% | 65.1% | 91.5% | 93.6% |
| EBITDA Margin | 107.8% | 1.1% | 20.6% | 76.1% |
| EBITDAR | 637 | 11 | 272 | 1,109 |
| EBITDAR Margin | 107.8% | 1.1% | 20.6% | 76.1% |
| EBIT Margin | 94.8% | -12.7% | 14.4% | 65.8% |
| Net Profit Margin | 107.8% | 1.0% | 72.8% | 58.3% |
| Operating Expense % of Sales | 8.8% | 64.1% | 70.9% | 17.5% |
| Returns | ||||
| Return on Assets (ROA) | 37.3% | 0.6% | 35.4% | 23.9% |
| Return on Equity (ROE) | 37.7% | 0.6% | 36.1% | 24.2% |
| ROIC [EBIT / Invested Capital] | 35.4% | -8.7% | 8.3% | 41.4% |
| Leverage & debt balances | ||||
| Debt-to-Assets | 0.0% | 0.0% | 0.0% | 0.0% |
| Debt-to-Equity | 0.00x | 0.00x | 0.00x | 0.00x |
| Debt-to-EBITDA | 0.00x | 0.00x | 0.00x | 0.00x |
| Equity-to-Assets | 98.8% | 98.8% | 97.9% | 98.7% |
| Net Debt | -105 | -155 | -358 | -1,193 |
| Cash & Equivalents | 105 | 155 | 358 | 1,193 |
| Total Debt | N/A | N/A | N/A | N/A |
| Liquidity & working capital | ||||
| Current Ratio | 1.00x | 1.00x | 1.00x | 1.00x |
| Quick Ratio | -7086.80x | 1.00x | 1.00x | 1.00x |
| Cash Ratio | 10492.50x | 15508.00x | 35846.90x | 119327.70x |
| Total Current Assets | 0 | 0 | 0 | 0 |
| Total Current Liabilities | 0 | 0 | 0 | 0 |
| Inventory | 71 | N/A | N/A | N/A |
| Trade Receivables | 92 | 92 | 108 | 75 |
| Trade Payables | 4 | 4 | 41 | 23 |
| Net Working Capital | 0 | 0 | 0 | 0 |
| Net Working Capital % of Revenue | 0.0% | 0.0% | 0.0% | 0.0% |
| Trade Working Capital | 159 | 88 | 67 | 52 |
| Trade Working Capital % of Revenue | 26.9% | 8.3% | 5.1% | 3.6% |
| Change in Trade Working Capital | N/A | -71 | -21 | -15 |
| Turnover & efficiency | ||||
| Inventory Turnover | 0.09x | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | 4252.2 | N/A | N/A | N/A |
| Receivables Turnover | 6.44x | 11.62x | 12.24x | 19.34x |
| Days Sales Outstanding (DSO) | 56.7 | 31.4 | 29.8 | 18.9 |
| Payables Turnover | 1.59x | 101.95x | 2.73x | 3.98x |
| Days Payable Outstanding (DPO) | 229.5 | 3.6 | 133.8 | 91.8 |
| Cash Conversion Cycle | 4079.4 days | 27.8 days | -104.0 days | -72.9 days |
| Asset Turnover | 0.35x | 0.62x | 0.49x | 0.41x |
| Cash flow & dividends | ||||
| Operating Cash Flow | N/A | N/A | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | N/A | N/A | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | N/A | N/A | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →